Introduction:Basic information about CAS 63-39-8|Uridine triphosphate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Uridine triphosphate |
|---|
| CAS Number | 63-39-8 | Molecular Weight | 484.14100 |
|---|
| Density | 2.106 g/cm3 | Boiling Point | / |
|---|
| Molecular Formula | C9H15N2O15P3 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 113ºC |
|---|
Names
| Name | utp |
|---|
| Synonym | More Synonyms |
|---|
Uridine triphosphate BiologicalActivity
| Description | Uridine triphosphate (UTP;Uridine 5'-triphosphate) is a pyrimidine nucleoside triphosphate that participates in glycogen metabolism and synthesis of RNA during transcription. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>CancerResearch Areas >>Cardiovascular DiseaseResearch Areas >>Inflammation/Immunology |
|---|
| In Vitro | Uridine triphosphate treatment induces Schwannoma cell migration through activation of P2Y2 receptors and through the increase of extracellular matrix metalloproteinase-2 (MMP-2) activation and expression[1]. Uridine triphosphate-induced proliferation is mediated by protein kinase D, Src-family tyrosine kinase, Ca/calmodulin-dependent protein kinase II, phosphatidylinositol 3-kinase (PI3K), Akt, and phospholipase D. Uridine triphosphate increases phosphorylation of Akt through protein kinase C, Src-family tyrosine kinase, Ca/calmodulin-dependent protein kinase II, and PI3K[2]. |
|---|
| In Vivo | Uridine triphosphate reduces mitochondrial calcium levels following hypoxia. Early or late uridine triphosphate preconditioning is effective to reduce infarct size and superior myocardial function[3]. Uridine triphosphate treatment increases the number of monocytes and macrophages infiltrating the pouch and up-regulates the gene expression of IL-4 and IL-13 in the regional lymph nodes[4]. |
|---|
| Cell Assay | Pancreatic duct epithelial cells are treated with (0.1 μM-1 mM) uridine triphosphate. BrdU is added after different time points (12-24 hours). Proliferation is measured using the BrdU incorporation assay in triplicate[2]. |
|---|
| Animal Admin | Rats: Four main groups are tested: (1) sham without LAD ligation, (2) LAD ligation, (3) injected with UTP (0.44 µg/kg i.v.) 30 min before MI, (4) UTP injection (4.4 µg/kg i.v.) 24 h prior to MI. Several different concentrations of UTP are tested (0.044–44.4 µg/kg). Left ventricular systolic pressure (LVSP), end-diastolic pressure (LVEDP) and heart rates are monitored before, after UTP treatment and post MI[3]. |
|---|
| References | [1]. Lamarca A, et al. Uridine 5'-triphosphate promotes in vitro Schwannoma cell migration through matrix metalloproteinase-2 activation. PLoS One. 2014 Jun 6;9(6):e98998. [2]. Choi JH, et al. Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor. Pancreas. 2013 May;42(4):680-6. [3]. Yitzhaki S, et al. Uridine-5'-triphosphate (UTP) reduces infarct size and improves rat heart function aftermyocardial infarct. Biochem Pharmacol. 2006 Oct 16;72(8):949-55. [4]. Iwaki Y, et al. Enhancement of antibody production against rabies virus by uridine 5'-triphosphate in mice. Microbes Infect. 2014 Mar;16(3):196-202. |
|---|
Chemical & Physical Properties
| Density | 2.106 g/cm3 |
|---|
| Molecular Formula | C9H15N2O15P3 |
|---|
| Molecular Weight | 484.14100 |
|---|
| Flash Point | 113ºC |
|---|
| Exact Mass | 483.96900 |
|---|
| PSA | 293.80000 |
|---|
| InChIKey | PGAVKCOVUIYSFO-XVFCMESISA-N |
|---|
| SMILES | O=c1ccn(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2O)c(=O)[nH]1 |
|---|
| Storage condition | −20°C |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- YU8083000
- CHEMICAL NAME :
- Uridine, 5'-(tetrahydrogen triphosphate)
- CAS REGISTRY NUMBER :
- 63-39-8
- BEILSTEIN REFERENCE NO. :
- 0071520
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C9-H15-N2-O15-P3
- MOLECULAR WEIGHT :
- 484.17
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA - TYPE OF TEST :
- Mutation test systems - not otherwise specified
- TEST SYSTEM :
- Human Cells - not otherwise specified
- DOSE/DURATION :
- 1 mmol/L
- REFERENCE :
- JIDEAE Journal of Investigative Dermatology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1938- Volume(issue)/page/year: 65,52,1975
|
Safety Information
| Hazard Codes | Xn |
|---|
| Risk Phrases | R20/21/22 |
|---|
| Safety Phrases | 22-26-36 |
|---|
| WGK Germany | 1 |
|---|
Synonyms
| uridine-triphosphate |
| Uteplex |
| [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate |
| Uridine 5'-triphosphoric acid |
| uridine 5'-O-triphosphate |
| MFCD00274571 |
| 5'-UTP |
| uridine 5'-triphosphate |
| EINECS 243-347-5 |
| Uridine triphosphate |
| Uridine 5'-(tetrahydrogen triphosphate) |